Misdiagnosis Patterns and Surgical Considerations

Dr. Bouberhan addresses misdiagnosis frequency, noting literature reports of approximately 50% misdiagnosis rates. Most commonly, patients undergo surgery presuming uterine fibroid diagnosis, with PEComa identification occurring only after pathological evaluation. This pattern reflects the radiological similarity between PEComas and benign leiomyomas, emphasizing the importance of maintaining diagnostic suspicion for atypical presentations.

PEComas can occur throughout the gynecologic tract beyond the uterine corpus, presenting as cervical or endometrial cavity polyps with polypoid appearances. Adnexal involvement may mimic ovarian cysts, particularly in torsion settings. Young patients with atypically behaving masses warrant consideration of PEComa diagnosis, though definitive identification requires pathological confirmation.

Dr. Choy contrasts sarcoma practice approaches, noting routine biopsy protocols for suspected sarcomas versus gynecologic practice patterns where surgical intervention often precedes definitive diagnosis. Many patients initially see benign gynecologists before oncologic referral, with planned hysterectomy or fibroidectomy proceeding based on radiological findings alone. This creates scenarios where surgical resection occurs without prior tissue diagnosis, potentially leading to inadequate initial surgical approaches.

Surgical decision-making becomes complex when benign PEComas are identified post-hysterectomy, raising questions about procedure necessity. No specific guidelines provide evidence-based recommendations for hysterectomy requirements in benign or uncertain malignant potential cases. Limited case series suggest comparable recurrence rates for conservative versus extensive approaches in benign phenotypes, though statistical certainty remains lacking due to small patient numbers.

Additional surgical controversies include bilateral salpingo-oophorectomy necessity, with limited data supporting routine ovarian removal given that tumors typically remain localized without obvious metastases. However, small case series preclude definitive recommendations. Simple hysterectomy potentially spares patients from surgical menopause compared to complete salpingo-oophorectomy. Similarly, lymphadenectomy lacks strong data support given rare lymph node metastases, with most experts avoiding routine lymph node sampling absent radiographic abnormalities.

The oophorectomy discussion centers on complete resection versus hormonal manipulation, though no evidence supports estrogen suppression benefits for PEComa treatment. Most tumors demonstrate TSC1/TSC2 mutation-driven pathways rather than estrogen-dependence, making anti-estrogen therapy unnecessary. Oophorectomy consideration should focus on anatomical proximity or suspected ovarian involvement rather than systemic hormone suppression.